Therefore, we have demonstrated that LPS stimulates PKCδ activation through TGFβ1 signaling, and that PKCδ subsequently further amplifies fibrosis in NASH. The gene discussed is PRKCD; the disease is metabolic dysfunction-associated steatohepatitis.